摘要:
The invention concerns the treatment of obesity, in particular visceral abdominal obesity. More specifically, the invention concerns the use of selective 15-LO inhibitors for preparing medicines useful in the treatment of obesity, or at least visceral abdominal obesity, and/or its consequences.